Loading...

Monoclonal Antibodies: Stanford Academia-Industry Collaboration

42,477 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on May 22, 2008

August 22, 2007 presentation by Ron Levy for the Stanford School of Medicine Medcast lecture series.

Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective.

Stanford University School of Medicine:
http://med.stanford.edu/

Stanford University Channel on YouTube:
http://www.youtube.com/stanforduniver...

  • Category

  • License

    • Standard YouTube License

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...